- Home
- ADPT vs CRSR Comparison
ADPT vs CRSR Comparison
Compare ADPT & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- CRSR
- Stock Information
- Founded
- ADPT 2009
- CRSR 1994
- Country
- ADPT United States
- CRSR United States
- Employees
- ADPT N/A
- CRSR N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- CRSR Computer Manufacturing
- Sector
- ADPT Health Care
- CRSR Technology
- Exchange
- ADPT Nasdaq
- CRSR Nasdaq
- Market Cap
- ADPT 1.1B
- CRSR 1.1B
- IPO Year
- ADPT 2019
- CRSR 2020
- Fundamental
- Price
- ADPT $7.33
- CRSR $6.03
- Analyst Decision
- ADPT Strong Buy
- CRSR Buy
- Analyst Count
- ADPT 5
- CRSR 6
- Target Price
- ADPT $9.40
- CRSR $10.17
- AVG Volume (30 Days)
- ADPT 2.4M
- CRSR 1.1M
- Earning Date
- ADPT 05-01-2025
- CRSR 05-06-2025
- Dividend Yield
- ADPT N/A
- CRSR N/A
- EPS Growth
- ADPT N/A
- CRSR N/A
- EPS
- ADPT N/A
- CRSR N/A
- Revenue
- ADPT $178,957,000.00
- CRSR $1,316,379,000.00
- Revenue This Year
- ADPT $21.20
- CRSR $16.15
- Revenue Next Year
- ADPT $22.06
- CRSR $10.40
- P/E Ratio
- ADPT N/A
- CRSR N/A
- Revenue Growth
- ADPT 5.10
- CRSR N/A
- 52 Week Low
- ADPT $2.28
- CRSR $5.60
- 52 Week High
- ADPT $9.01
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- ADPT 43.95
- CRSR 27.66
- Support Level
- ADPT $7.38
- CRSR $5.92
- Resistance Level
- ADPT $8.30
- CRSR $6.70
- Average True Range (ATR)
- ADPT 0.75
- CRSR 0.65
- MACD
- ADPT -0.04
- CRSR -0.12
- Stochastic Oscillator
- ADPT 33.85
- CRSR 7.23
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.